Genton B - Search Results

1

The malaria vaccine development program in Papua New Guinea.

Genton B, Anders RF, Alpers MP, Reeder JC. Genton B, et al. Trends Parasitol. 2003 Jun;19(6):264-70. doi: 10.1016/s1471-4922(03)00111-9. Trends Parasitol. 2003. PMID: 12798084 Review.

2

Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children.

Genton B, Al-Yaman F, Betuela I, Anders RF, Saul A, Baea K, Mellombo M, Taraika J, Brown GV, Pye D, Irving DO, Felger I, Beck HP, Smith TA, Alpers MP. Genton B, et al. Vaccine. 2003 Dec 8;22(1):30-41. doi: 10.1016/s0264-410x(03)00536-x. Vaccine. 2003. PMID: 14604568 Clinical Trial.

3

Strain-specific humoral response to a polymorphic malaria vaccine.

Flück C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, Anders R, Saul A, Genton B, Felger I. Flück C, et al. Among authors: genton b. Infect Immun. 2004 Nov;72(11):6300-5. doi: 10.1128/IAI.72.11.6300-6305.2004. Infect Immun. 2004. PMID: 15501757 Free PMC article. Clinical Trial.

4

Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity.

Flück C, Schöpflin S, Smith T, Genton B, Alpers MP, Beck HP, Felger I. Flück C, et al. Among authors: genton b. Infect Genet Evol. 2007 Jan;7(1):44-51. doi: 10.1016/j.meegid.2006.03.006. Epub 2006 May 2. Infect Genet Evol. 2007. PMID: 16647307 Clinical Trial.

5

Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.

Genton B, Baea K, Lorry K, Ginny M, Wines B, Alpers MP. Genton B, et al. P N G Med J. 2005 Sep-Dec;48(3-4):141-50. P N G Med J. 2005. PMID: 17212060

6

Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.

Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B. Marfurt J, et al. Among authors: genton b. Am J Trop Med Hyg. 2007 Nov;77(5):947-54. Am J Trop Med Hyg. 2007. PMID: 17984359 Clinical Trial.

7

The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.

Marfurt J, Müller I, Sie A, Oa O, Reeder JC, Smith TA, Beck HP, Genton B. Marfurt J, et al. Among authors: genton b. Malar J. 2008 Apr 19;7:61. doi: 10.1186/1475-2875-7-61. Malar J. 2008. PMID: 18423045 Free PMC article.

8

Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea.

Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Müller I. Genton B, et al. PLoS Med. 2008 Jun 17;5(6):e127. doi: 10.1371/journal.pmed.0050127. PLoS Med. 2008. PMID: 18563961 Free PMC article.

9

Lack of multiple copies of pfmdr1 gene in Papua New Guinea.

Hodel EM, Marfurt J, Müller D, Rippert A, Borrmann S, Müller I, Reeder JC, Siba P, Genton B, Beck HP. Hodel EM, et al. Among authors: genton b. Trans R Soc Trop Med Hyg. 2008 Nov;102(11):1151-3. doi: 10.1016/j.trstmh.2008.05.017. Epub 2008 Jul 2. Trans R Soc Trop Med Hyg. 2008. PMID: 18599099

10

Vaccines against malaria: perspectives from Papua New Guinea.

Mueller I, Genton B, Betuela I, Alpers MP. Mueller I, et al. Among authors: genton b. Hum Vaccin. 2010 Jan;6(1):17-20. doi: 10.4161/hv.6.1.10332. Epub 2010 Jan 15. Hum Vaccin. 2010. PMID: 20173407 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

326 results

Search Page